[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oncology Drugs Industry Market Analysis & Forecast 2018-2023

January 2018 | 125 pages | ID: G6E8CDC09F6EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the Global Oncology Drugs Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Global Oncology Drugs Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.

Global Oncology Drugs Market: Product Segment Analysis

Blood Cancer
Breast Cancer
Others

Global Oncology Drugs Market: Application Segment Analysis

Chemotherapy
Targeted Therapy
Others

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 ONCOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Drugs
1.2 Oncology Drugs Market Segmentation by Type in 2016
  1.2.1 Global Production Market Share of Oncology Drugs by Type in 2016
  1.2.1 Blood Cancer
  1.2.2 Breast Cancer
  1.2.3 Others
1.3 Oncology Drugs Market Segmentation by Application in 2016
  1.3.1 Oncology Drugs Consumption Market Share by Application in 2016
  1.3.2 Chemotherapy
  1.3.3 Targeted Therapy
  1.3.4 Others
1.4 Oncology Drugs Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Oncology Drugs (2013-2023)
  1.5.1 Global Product Sales and Growth Rate (2013-2023)
  1.5.2 Global Product Revenue and Growth Rate (2013-2023)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON ONCOLOGY DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL ONCOLOGY DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Oncology Drugs Production and Share by Manufacturers (2016 and 2017)
3.2 Global Oncology Drugs Revenue and Share by Manufacturers (2016 and 2017)
3.3 Global Oncology Drugs Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Oncology Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Drugs Market Competitive Situation and Trends
  3.5.1 Oncology Drugs Market Concentration Rate
  3.5.2 Oncology Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL ONCOLOGY DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

4.1 Global Oncology Drugs Production by Region (2013-2018)
4.2 Global Oncology Drugs Production Market Share by Region (2013-2018)
4.3 Global Oncology Drugs Revenue (Value) and Market Share by Region (2013-2018)
4.4 Global Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
4.5 North America Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.5.1 North AmericaOncology DrugsProduction and Market Share by Manufacturers
  4.5.2 North AmericaOncology DrugsProduction and Market Share by Type
  4.5.3 North AmericaOncology DrugsProduction and Market Share by Application
4.6 Europe Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.6.1 EuropeOncology DrugsProduction and Market Share by Manufacturers
  4.6.2 Europe Oncology Drugs Production and Market Share by Type
  4.6.3 Europe Oncology Drugs Production and Market Share by Application
4.7 China Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.7.1 ChinaOncology DrugsProduction and Market Share by Manufacturers
  4.7.2 China Oncology Drugs Production and Market Share by Type
  4.7.3 China Oncology Drugs Production and Market Share by Application
4.8 Japan Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.8.1 Japan Oncology Drugs Production and Market Share by Manufacturers
  4.8.2 Japan Oncology Drugs Production and Market Share by Type
  4.8.3 Japan Oncology Drugs Production and Market Share by Application
4.9 Southeast Asia Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.9.1 Southeast Asia Oncology Drugs Production and Market Share by Manufacturers
  4.9.2 Southeast Asia Oncology Drugs Production and Market Share by Type
  4.9.3 Southeast Asia Oncology Drugs Production and Market Share by Application
4.10 India Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
  4.10.1 India Oncology Drugs Production and Market Share by Manufacturers
  4.10.2 India Oncology Drugs Production and Market Share by Type
  4.10.3 India Oncology Drugs Production and Market Share by Application

CHAPTER 5 GLOBAL ONCOLOGY DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)

5.1 Global Oncology Drugs Consumption by Regions (2013-2018)
5.2 North America Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)
5.3 Europe Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)
5.4 China Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)
5.5 Japan Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)
5.6 Southeast Asia Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)
5.7 India Oncology Drugs Production, Consumption, Export, Import by Regions (2013-2018)

CHAPTER 6 GLOBAL ONCOLOGY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Oncology Drugs Production and Market Share by Type (2013-2018)
6.2 Global Oncology Drugs Revenue and Market Share by Type (2013-2018)
6.3 Global Oncology Drugs Price by Type (2013-2018)
6.4 Global Oncology Drugs Production Growth by Type (2013-2018)

CHAPTER 7 GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Global Oncology Drugs Consumption and Market Share by Application (2013-2018)
7.2 Global Oncology Drugs Revenue and Market Share by Type (2013-2018)
7.3 Global Oncology Drugs Consumption Growth Rate by Application (2013-2018)
7.4 Market Drivers and Opportunities
  7.4.1 Potential Applications
  7.4.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL ONCOLOGY DRUGS MANUFACTURERS ANALYSIS

8.1 Roche
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.1.4 Business Overview
8.2 Novartis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.2.4 Business Overview
8.3 Celgene
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.3.4 Business Overview
8.4 Amgen
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.4.4 Business Overview
8.5 Johnson & Johnson
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.5.4 Business Overview
8.6 GlaxoSmithKline
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.6.4 Business Overview
8.7 Eli lilly & Co
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.7.4 Business Overview
8.8 Pfizer
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.8.4 Business Overview
8.9 Merck & Co.
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.9.4 Business Overview


CHAPTER 9 ONCOLOGY DRUGS MANUFACTURING COST ANALYSIS

9.1 Oncology Drugs Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Oncology Drugs

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Oncology Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL ONCOLOGY DRUGS MARKET FORECAST (2018-2023)

13.1 Global Oncology Drugs Production, Revenue Forecast (2018-2023)
13.2 Global Oncology Drugs Production, Consumption Forecast by Regions (2018-2023)
13.3 Global Oncology Drugs Production Forecast by Type (2018-2023)
13.4 Global Oncology Drugs Consumption Forecast by Application (2018-2023)
13.5 Oncology Drugs Price Forecast (2018-2023)

CHAPTER 14 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Drugs
Figure Global Production Market Share of Oncology Drugs by Breast Cancer016
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Oncology Drugs Consumption Market Share by Application in 2016
Figure Chemotherapy Examples
Figure Targeted Therapy Examples
Figure Others Examples
Figure North America Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure China Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Japan Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Southeast Asia Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure India Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oncology Drugs Revenue (Million UDS) and Growth Rate (2013-2023)
Table Global Oncology Drugs Capacity of Key Manufacturers (2016 and 2017)
Table Global Oncology Drugs Capacity Market Share by Manufacturers (2016 and 2017)
Figure Global Oncology Drugs Capacity of Key Manufacturers in 2016
Figure Global Oncology Drugs Capacity of Key Manufacturers in 2017
Table Global Oncology Drugs Production of Key Manufacturers (2016 and 2017)
Table Global Oncology Drugs Production Share by Manufacturers (2016 and 2017)
Figure 2015 Oncology Drugs Production Share by Manufacturers
Figure 2016 Oncology Drugs Production Share by Manufacturers
Table Global Oncology Drugs Revenue (Million USD) by Manufacturers (2016 and 2017)
Table Global Oncology Drugs Revenue Share by Manufacturers (2016 and 2017)
Table 2015 Global Oncology Drugs Revenue Share by Manufacturers
Table 2016 Global Oncology Drugs Revenue Share by Manufacturers
Table Global Market Oncology Drugs Average Price of Key Manufacturers (2016 and 2017)
Figure Global Market Oncology Drugs Average Price of Key Manufacturers in 2016
Table Manufacturers Oncology Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Drugs Product Type
Figure Oncology Drugs Market Share of Top 3 Manufacturers
Figure Oncology Drugs Market Share of Top 5 Manufacturers
Table Global Oncology Drugs Capacity by Regions (2013-2018)
Figure Global Oncology Drugs Capacity Market Share by Regions (2013-2018)
Figure Global Oncology Drugs Capacity Market Share by Regions (2013-2018)
Figure 2015 Global Oncology Drugs Capacity Market Share by Regions
Table Global Oncology Drugs Production by Regions (2013-2018)
Figure Global Oncology Drugs Production and Market Share by Regions (2013-2018)
Figure Global Oncology Drugs Production Market Share by Regions (2013-2018)
Figure 2015 Global Oncology Drugs Production Market Share by Regions
Table Global Oncology Drugs Revenue by Regions (2013-2018)
Table Global Oncology Drugs Revenue Market Share by Regions (2013-2018)
Table 2015 Global Oncology Drugs Revenue Market Share by Regions
Table Global Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table North America Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Europe Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table China Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Japan Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Southeast Asia Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table India Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Global Oncology Drugs Consumption Market by Regions (2013-2018)
Table Global Oncology Drugs Consumption Market Share by Regions (2013-2018)
Figure Global Oncology Drugs Consumption Market Share by Regions (2013-2018)
Figure 2015 Global Oncology Drugs Consumption Market Share by Regions
Table North America Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table Europe Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table China Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table Japan Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table Southeast Asia Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table India Oncology Drugs Production, Consumption, Import & Export (2013-2018)
Table Global Oncology Drugs Production by Type (2013-2018)
Table Global Oncology Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Oncology Drugs by Type (2013-2018)
Figure 2015 Production Market Share of Oncology Drugs by Type
Table Global Oncology Drugs Revenue by Type (2013-2018)
Table Global Oncology Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Oncology Drugs by Type (2013-2018)
Figure 2015 Revenue Market Share of Oncology Drugs by Type
Table Global Oncology Drugs Price by Type (2013-2018)
Figure Global Oncology Drugs Production Growth by Type (2013-2018)
Table Global Oncology Drugs Consumption by Application (2013-2018)
Table Global Oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Global Oncology Drugs Consumption Market Share by Application in 2016
Table Global Oncology Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Oncology Drugs Consumption Growth Rate by Application (2013-2018)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Roche Oncology Drugs Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Novartis Oncology Drugs Market Share (2013-2018)
Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgene Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgene Oncology Drugs Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Amgen Oncology Drugs Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Johnson & Johnson Oncology Drugs Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table GlaxoSmithKline Oncology Drugs Market Share (2013-2018)
Table Eli lilly & Co Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli lilly & Co Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Eli lilly & Co Oncology Drugs Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer Oncology Drugs Market Share (2013-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck & Co. Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Merck & Co. Oncology Drugs Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure Global Oncology Drugs Production and Growth Rate Forecast (2018-2023)
Figure Global Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Table Global Oncology Drugs Production Forecast by Regions (2018-2023)
Table Global Oncology Drugs Consumption Forecast by Regions (2018-2023)
Table Global Oncology Drugs Production Forecast by Type (2018-2023)
Table Global Oncology Drugs Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Roche Novartis Celgene Amgen Johnson & Johnson GlaxoSmithKline Eli lilly & Co Pfizer Merck & Co.


More Publications